Advertisement

Topics

Viroblock SA Company Profile

16:24 EST 21st November 2017 | BioPortfolio

Viroblock is dedicated to developing and commercializing a new generation of anti-viral products with a novel mechanism of action against enveloped viruses. Enveloped viruses represent more than 60% of all existing viruses and include major human pathogens such as human and avian influenzas, the hepatitis B and C viruses and the AIDS virus.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Viroblock SA

Viroblock is dedicated to developing and commercializing a new generation of anti-viral products with a novel mechanism of action against enveloped viruses. Enveloped viruses represent more than 6...

More Information about "Viroblock SA" on BioPortfolio

We have published hundreds of Viroblock SA news stories on BioPortfolio along with dozens of Viroblock SA Clinical Trials and PubMed Articles about Viroblock SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Viroblock SA Companies in our database. You can also find out about relevant Viroblock SA Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...


Corporate Database Quicklinks



Searches Linking to this Company Record